Association Between Topical Calcineurin Inhibitor Use and Risk of Cancer, Including Lymphoma, Keratinocyte Carcinoma, and Melanoma: A Systematic Review and Meta-analysis.

Lam, Megan; Zhu, Jie Wei; Tadrous, Mina; Drucker, Aaron M

Lam, Megan; Zhu, Jie Wei; Tadrous, Mina; Drucker, Aaron M.

Affiliation

Lam M; Michael G. DeGroote School of Medicine, Faculty of Medicine, McMaster University, Hamilton, Ontario, Canada.
Zhu JW; Michael G. DeGroote School of Medicine, Faculty of Medicine, McMaster University, Hamilton, Ontario, Canada.
Tadrous M; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
Drucker AM; Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.

JAMA Dermatol ; 157(5): 549-558, 2021 05 01.

Article in En | MEDLINE | ID: mdl-33787818

Subject(s)

Calcineurin Inhibitors/administration & dosage; Carcinoma/epidemiology; Keratinocytes/pathology; Lymphoma/epidemiology; Melanoma/epidemiology; Skin Neoplasms/epidemiology; Administration, Topical; Carcinoma/diagnosis; Humans; Lymphoma/diagnosis; Melanoma/diagnosis; Skin Neoplasms/diagnosis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma / Keratinocytes / Calcineurin Inhibitors / Lymphoma / Melanoma Type of study: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Systematic_reviews Limits: Humans Language: En Journal: JAMA Dermatol Year: 2021 Type: Article Affiliation country: Canada

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google